Mental health in the ICU: a 2,000-Patient study aims to uncover hidden risks
NCT ID NCT07705802
First seen Jul 15, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study follows 2,000 adults with severe mental illness (such as schizophrenia, bipolar disorder, or severe depression) who are admitted to intensive care units (ICUs) in France. Researchers track their survival and other outcomes for up to 12 months to identify factors that predict recovery or complications. The goal is to fill gaps in knowledge about how this vulnerable group responds to critical care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how to better care for people with severe mental illness in intensive care, potentially reducing deaths and complications.
- What could go wrong
- This is an observational study, not a treatment trial, so it cannot prove what works. Results may vary across different ICUs and patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with severe mental illnesses admitted to the ICU for unscheduled medical management, urgent post-operative care, or due to a complication of elective surgery.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years. * Admission to a participating ICU. * Unscheduled ICU admission for medical management, urgent post-operative care, or due to a complication of elective surgery. * Pre-existing diagnosis of a severe mental illness prior to ICU admission, according to DSM-5 criteria: schizophrenia, schizoaffective disorder, severe major depressive episode, chronic depressive disorder, recurrent depressive disorder, or bipolar disorders. * Current chronic treatment with psychotropic medication at the time of enrollment (antidepressants, neuroleptics, other antipsychotics, lithium, or antiepileptic drugs used as mood stabilizers). * Non-opposition to participate from the patient; if the patient is unable to receive information, non-opposition from a relative/trusted person; for patients under guardianship or curatorship, non-opposition from both the legal guardian and the patient. Exclusion Criteria: * Scheduled ICU admission following elective surgery. * Prior enrollment in the REPSYRE study. * Inability to speak or understand French. * Homeless patients or individuals deprived of liberty. * Any other condition or reason that, in the investigator's judgment, might interfere with the evaluation of the study objectives.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
30 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU Ambroise Paré AP-HP
Boulogne-Billancourt, Hauts-de-Seine, 92100, France
-
CHU de Clermont-Ferrand
Clermont-Ferrand, Puy-de-Dôme, 63000, France
-
CHU de Lille - Hôpital Roger Salengro
Lille, Nord, 59037, France
-
Centre Hospitalier Bretagne Atlantique de Vannes
Vannes, Morbihan, 56017, France
-
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Toulon, Var, 83056, France
-
Centre Hospitalier Intercommunal de Compiègne-Noyon
Compiègne, 60200, France
-
Centre Hospitalier Simone Veil
Blois, Loir-et-Cher, 41000, France
-
Centre Hospitalier Universitaire de Nice
Nice, Alpes-Maritimes, 06001, France
-
Centre Hospitalier Universitaire de Rennes
Rennes, Ille-et-Vilaine, 35033, France
-
Centre Hospitalier d'Agen-Nerac
Agen, 47923, France
-
Centre Hospitalier d'Arles
Arles, 13200, France
-
Centre Hospitalier de Cahors
Cahors, Lot, 46000, France
-
Centre Hospitalier de Dieppe
Dieppe, 76202, France
-
Centre Hospitalier de Versailles
Le Chesnay, Yvelines, 78150, France
-
Grand Hôpital de l'Est Francilien - Site de Jossigny
Jossigny, Seine-et-Marne, 77600, France
-
Grand Hôpital de l'Est Francilien - Site de Meaux
Meaux, Seine-et-Marne, 77100, France
-
Groupe Hospitalier Littoral Atlantique
La Rochelle, Charente-Maritime, 17019, France
-
Groupe Hospitalier Nord Essonne - Site Paris-Saclay
Orsay, 91400, France
-
Groupe Hospitalier Sud Ile de France
Melun, Seine-et-Marne, 77000, France
-
Hôpital Bichat
Paris, Paris, 75018, France
-
Hôpital Européen Marseille
Marseille, 13331, France
-
Hôpital La Pitié Salpêtrière
Paris, Paris, 75013, France
-
Hôpital La Pitié Salpêtrière
Paris, Paris, 75013, France
-
Hôpital National d'Instruction des Armées de Sainte Anne
Toulon, Var, 83100, France
-
Hôpital Nord Franche Comté
Trévenans, Territoire de Belfort, 90400, France
-
Hôpital Privé Jacques Cartier - Ramsay Santé
Massy, 91300, France
-
Hôpital Saint Joseph
Paris, Paris, 75674, France
-
Hôpital Saint Louis (AP-HP)
Paris, Paris, 75010, France
-
Hôpital Tenon (AP-HP)
Paris, Paris, 75020, France
-
Hôpital privé Claude Galien
Quincy-sous-Sénart, Essonne, 91480, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five sessions to quiet trauma nightmares in bipolar disorder
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug